These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 21615608)

  • 1. Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation.
    Sekido Y
    Pathol Int; 2011 Jun; 61(6):331-44. PubMed ID: 21615608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LATS2 is a tumor suppressor gene of malignant mesothelioma.
    Murakami H; Mizuno T; Taniguchi T; Fujii M; Ishiguro F; Fukui T; Akatsuka S; Horio Y; Hida T; Kondo Y; Toyokuni S; Osada H; Sekido Y
    Cancer Res; 2011 Feb; 71(3):873-83. PubMed ID: 21245096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.
    Sato T; Sekido Y
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The WW domain protein Kibra acts upstream of Hippo in Drosophila.
    Baumgartner R; Poernbacher I; Buser N; Hafen E; Stocker H
    Dev Cell; 2010 Feb; 18(2):309-16. PubMed ID: 20159600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing.
    Miyanaga A; Masuda M; Tsuta K; Kawasaki K; Nakamura Y; Sakuma T; Asamura H; Gemma A; Yamada T
    J Thorac Oncol; 2015 May; 10(5):844-851. PubMed ID: 25902174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK.
    Poulikakos PI; Xiao GH; Gallagher R; Jablonski S; Jhanwar SC; Testa JR
    Oncogene; 2006 Sep; 25(44):5960-8. PubMed ID: 16652148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shedding light on Merlin's wizardry.
    Okada T; You L; Giancotti FG
    Trends Cell Biol; 2007 May; 17(5):222-9. PubMed ID: 17442573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
    Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
    Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded.
    Yu J; Zheng Y; Dong J; Klusza S; Deng WM; Pan D
    Dev Cell; 2010 Feb; 18(2):288-99. PubMed ID: 20159598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genes of Hippo signaling network act unconventionally in the control of germline proliferation in Drosophila.
    Sun S; Zhao S; Wang Z
    Dev Dyn; 2008 Jan; 237(1):270-5. PubMed ID: 18095349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-occurring Mutations of Tumor Suppressor Genes,
    Tranchant R; Quetel L; Tallet A; Meiller C; Renier A; de Koning L; de Reynies A; Le Pimpec-Barthes F; Zucman-Rossi J; Jaurand MC; Jean D
    Clin Cancer Res; 2017 Jun; 23(12):3191-3202. PubMed ID: 28003305
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular pathogenesis of malignant mesothelioma.
    Sekido Y
    Carcinogenesis; 2013 Jul; 34(7):1413-9. PubMed ID: 23677068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurofibromatosis type 2 (NF2)].
    Araki N; Takeshima H; Saya H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression.
    Xiao GH; Gallagher R; Shetler J; Skele K; Altomare DA; Pestell RG; Jhanwar S; Testa JR
    Mol Cell Biol; 2005 Mar; 25(6):2384-94. PubMed ID: 15743831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Merlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival.
    Stamenkovic I; Yu Q
    Curr Protein Pept Sci; 2010 Sep; 11(6):471-84. PubMed ID: 20491622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research progress of Merlin protein and its signal pathway in tumor].
    Zhu YJ; Shan CG
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(9):757-762. PubMed ID: 29771032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippo pathway inactivation through subcellular localization of NF2/merlin in outer cells of mouse embryos.
    Goda N; Ito Y; Saito S; Suzuki M; Bai H; Takahashi M; Wakai T; Kawahara M
    Development; 2024 Jul; 151(14):. PubMed ID: 39077779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes.
    Mizuno T; Murakami H; Fujii M; Ishiguro F; Tanaka I; Kondo Y; Akatsuka S; Toyokuni S; Yokoi K; Osada H; Sekido Y
    Oncogene; 2012 Dec; 31(49):5117-22. PubMed ID: 22286761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.
    Golovnina K; Blinov A; Akhmametyeva EM; Omelyanchuk LV; Chang LS
    BMC Evol Biol; 2005 Dec; 5():69. PubMed ID: 16324214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for diffuse pleural mesotheliomas in preclinical models by concurrent expression of NF2 and SuperHippo.
    Zhu R; Liu X; Zhang X; Zhong Z; Qi S; Jin R; Gu Y; Wang Y; Ling C; Chen K; Ye D; Yu FX
    Cell Rep Med; 2024 Oct; 5(10):101763. PubMed ID: 39368484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.